Literature DB >> 22387837

[Guidelines for the management of Crohn's disease].

Byong Duk Ye1, Suk-Kyun Yang, Sung Jae Shin, Kang Moon Lee, Byung Ik Jang, Jae Hee Cheon, Chang Hwan Choi, Young-Ho Kim, Heeyoung Lee.   

Abstract

Crohn's disease (CD) is a chronic inflammatory bowel disease (IBD) with uncertain etiopathogenesis. CD can involve any site of gastrointestinal tract from the mouth to anus and is associated with serious complications such as bowel strictures, perforations, and fistula formation. The incidence and prevalence rates of CD in Korea are still lower than those of Western countries, but have been rapidly increasing during the past decades. Although there are no definitive curative modalities for CD, various medical and surgical therapies are currently applied for diverse clinical situations of CD. However, a lot of decisions on the management of CD are made depending on the personal experiences and choices of physicians. To suggest preferable approaches to diverse problems of CD and to minimize the variations according to physicians, guidelines for the management of CD are needed. Therefore, IBD Study Group of the Korean Association for the Study of the Intestinal Diseases has set out to develop the guidelines for the management of CD in Korea. These guidelines were developed using the adaptation methods and encompass the treatment of inflammatory disease, stricturing disease, and penetrating disease. The guidelines also cover the indication of surgery, prevention of recurrence after surgery, and CD in pregnancy and lactation. These are the first Korean guidelines for the management of CD and the update with further scientific data and evidences is needed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22387837     DOI: 10.4166/kjg.2012.59.2.141

Source DB:  PubMed          Journal:  Korean J Gastroenterol        ISSN: 1598-9992


  10 in total

1.  Crohn's disease confined to the duodenum: A case report.

Authors:  Dong Jin Song; Il Soon Whang; Hyung Wook Choi; Cheol Yun Jeong; Sung Hoon Jung
Journal:  World J Clin Cases       Date:  2016-06-16       Impact factor: 1.337

Review 2.  Pharmacological- and non-pharmacological therapeutic approaches in inflammatory bowel disease in adults.

Authors:  Gerda C Leitner; Harald Vogelsang
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-02-06

3.  Significant risk and associated factors of active tuberculosis infection in Korean patients with inflammatory bowel disease using anti-TNF agents.

Authors:  Eun Soo Kim; Geun Am Song; Kwang Bum Cho; Kyung Sik Park; Kyeong Ok Kim; Byung Ik Jang; Eun Young Kim; Seong Woo Jeon; Hyun Seok Lee; Chang Heon Yang; Yong Kook Lee; Dong Wook Lee; Sung Kook Kim; Tae Oh Kim; Jonghun Lee; Hyung Wook Kim; Sam Ryong Jee; Seun Ja Park; Hyun Jin Kim
Journal:  World J Gastroenterol       Date:  2015-03-21       Impact factor: 5.742

4.  Clinical Course of Hepatitis B Viral Infection in Patients Undergoing Anti-Tumor Necrosis Factor α Therapy for Inflammatory Bowel Disease.

Authors:  Ji Min Lee; Shu-Chen Wei; Kang-Moon Lee; Byong Duk Ye; Ren Mao; Hyun-Soo Kim; Soo Jung Park; Sang Hyoung Park; Eun Hye Oh; Jong Pil Im; Byung Ik Jang; Dae Bum Kim; Ken Takeuchi
Journal:  Gut Liver       Date:  2022-05-15       Impact factor: 4.321

5.  Unusual Case of Cerebral Venous Thrombosis in Patient with Crohn's Disease.

Authors:  Inha Kim; Kyung-Hyun Min; Minju Yeo; Ji Seon Kim; Sung Hyun Lee; Sang Soo Lee; Kyeong Seob Shin; Sei Jin Youn; Dong Ick Shin
Journal:  Case Rep Neurol       Date:  2015-05-13

6.  Life-threatening lower gastrointestinal hemorrhage in pediatric Crohn's disease.

Authors:  Earl Kim; Yunkoo Kang; Mi Jung Lee; Young Nyun Park; Hong Koh
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2013-03-31

7.  Vaccination and complementary and alternative medicine in patients with inflammatory bowel disease.

Authors:  Sung Bae Kim; Soo Jung Park; Sook Hee Chung; Kyu Yeon Hahn; Do Chang Moon; Sung Pil Hong; Jae Hee Cheon; Tae Il Kim; Won Ho Kim
Journal:  Intest Res       Date:  2014-04-29

Review 8.  Second Korean guidelines for the management of Crohn's disease.

Authors:  Jae Jun Park; Suk-Kyun Yang; Byong Duk Ye; Jong Wook Kim; Dong Il Park; Hyuk Yoon; Jong Pil Im; Kang Moon Lee; Sang Nam Yoon; Heeyoung Lee
Journal:  Intest Res       Date:  2017-01-31

9.  Factors Contributing to the Preference of Korean Patients with Crohn's Disease When Selecting an Anti-Tumor Necrosis Factor Agent (CHOICE Study).

Authors:  Eun Soo Kim; Kyeong Ok Kim; Byung Ik Jang; Chang Kyun Lee; Hyo Jong Kim; Kang-Moon Lee; You Sun Kim; Chang Soo Eun; Sung-Ae Jung; Suk-Kyun Yang; Jun Lee; Tae-Oh Kim; Yunho Jung; Geom Seog Seo; Soon Man Yoon
Journal:  Gut Liver       Date:  2016-05-23       Impact factor: 4.519

10.  Cerebral venous thrombosis in a patient with Crohn's disease.

Authors:  Young-Hak Cho; Min Kyu Chae; Jae Myung Cha; Joung Il Lee; Kwang Ro Joo; Hyun Phil Shin; Il Hyun Baek; Jung Won Jeon; Jun Uk Lim; In Taik Hong; Hye-Jin Ki; Jae Bin Kang
Journal:  Intest Res       Date:  2016-01-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.